Since tracking began
$MED has been tracked since 2026-03-01. It was down 32.5% from its 52-week high then — now down -30.7%.
Roughly where it joined — no recovery, no further break. It bottomed 38.4% below that high along the way.
Decline from the 52-week high as it stood on 2026-03-02 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.
Structural break signals
MED qualifies for the Red List on decline depth.
The structural read
What price action says about MED.
MED qualifies for the Red List on decline depth — down -30.7% from its rolling 252-day high. Past 30% with the high set inside the last four months — the recency clause that often precedes further breakdown.
Cross-confirmation: also showing 5/5 bearish time frames.
Cross-confirmation: decline sigma also reads 6.2σ over 20 bars.
Upstream TFC read: weak alignment, current phase daily. Last bar types — daily 2U (red), weekly 1 (red), monthly 1 (green).
Earnings on file: 2026-02-17. Tiering is unaffected by earnings dates — listings reflect price structure only.
52-week range
Sector context · Consumer Cyclical
127 other Consumer Cyclical tickers are on Broken Stocks.
Worst in sector: CWH (-67.3%). Least-bad: CCL (-20.3%). See all Consumer Cyclical listings →
Questions about MED
What people ask.
Why is MED on Broken Stocks?
MED qualifies for the Red List on decline depth. It is down -30.7% from its rolling 252-day high of $15.46, set on 2025-07-10 — 365d ago.
Is MED a falling knife?
Not by the strict technical definition. MED is down -30.7% from its 52-week high, but that high was set 365d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. MED is still on the Red List for decline depth, but the freshness component of a falling knife is missing.
Is MED a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is MED trading inside its 52-week range?
At $10.72, MED sits 24.0% of the way from its 52-week low ($9.22) to its 52-week high ($15.46). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has MED been declining?
The current 30.7% decline accrued over 365d, which annualizes to roughly -30.7% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does MED compare to its sector?
There are 127 other Consumer Cyclical tickers on Broken Stocks: 48 Red, 39 Amber, 40 Watch, with 45 showing recovering structural signals. Median sector decline is -34.4% — MED's decline is shallower than the sector median.
Does MED's earnings date affect its tier?
No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-02-17) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.